Table 2. Baseline characteristics of study population

	Patient in group n (%)						p
	Study population	IT (n=64)	CHBe+ (n=66)	IC (n=56)	VR (n=47)	CHBe- (n=43)
Sex male	176 (63.7)	30 (46.8)	48 (72.7)	32 (57.1)	33 (70.2)	33 (76.7)	0.004
Age
<30	37 (13.4)	11 (17.2)	20 (30.3)	5 (8.9)	1 (2)	0	<0.001
30-40	111 (40.2)	41 (64)	31 (47)	17 (30.4)	11 (23.4)	12 (27.9)
>40	128 (46.4)	12 (18.8)	15 (22.7)	34 (60.7)	35 (74.5)	31 (72.1)
HBV DNA (median logcps/ml)	6.8 (3.8-9.8)	7.44 (6.98-8.5)	8.23 (7-8.6)	3.46 (3.2-3.8)	5.31 (4.7-6.1)	6.12 (5.45-7.1)	<0.001*
Genotype
B	156 (69.3)	51 (79.7)	37 (57.8)	11 (78.6)	33 (76.7)	24 (75)
C, C+B	61 (27.3)	13 (20.3)	27 (42.2)	3 (21.4)	10 (23.3)	8 (25)	0.033

The percentages were vertically presented. HBV genotype were determined in 217 patients (n=64 in IT, n=64 in CHBe+, n=14 in IC, n=43 in VR, n=32 in CHBe-)
Kruskal Wallis test